全文获取类型
收费全文 | 2556篇 |
免费 | 152篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 104篇 |
妇产科学 | 33篇 |
基础医学 | 247篇 |
口腔科学 | 52篇 |
临床医学 | 361篇 |
内科学 | 646篇 |
皮肤病学 | 67篇 |
神经病学 | 86篇 |
特种医学 | 336篇 |
外国民族医学 | 1篇 |
外科学 | 261篇 |
综合类 | 70篇 |
预防医学 | 186篇 |
眼科学 | 68篇 |
药学 | 148篇 |
中国医学 | 3篇 |
肿瘤学 | 112篇 |
出版年
2023年 | 14篇 |
2021年 | 25篇 |
2020年 | 23篇 |
2019年 | 30篇 |
2018年 | 40篇 |
2017年 | 33篇 |
2016年 | 33篇 |
2015年 | 32篇 |
2014年 | 56篇 |
2013年 | 79篇 |
2012年 | 104篇 |
2011年 | 92篇 |
2010年 | 71篇 |
2009年 | 89篇 |
2008年 | 72篇 |
2007年 | 124篇 |
2006年 | 92篇 |
2005年 | 97篇 |
2004年 | 67篇 |
2003年 | 68篇 |
2002年 | 60篇 |
2001年 | 99篇 |
2000年 | 77篇 |
1999年 | 52篇 |
1998年 | 103篇 |
1997年 | 83篇 |
1996年 | 85篇 |
1995年 | 66篇 |
1994年 | 54篇 |
1993年 | 59篇 |
1992年 | 61篇 |
1991年 | 51篇 |
1990年 | 53篇 |
1989年 | 69篇 |
1988年 | 56篇 |
1987年 | 54篇 |
1986年 | 44篇 |
1985年 | 42篇 |
1984年 | 35篇 |
1983年 | 27篇 |
1982年 | 22篇 |
1981年 | 17篇 |
1980年 | 24篇 |
1979年 | 23篇 |
1978年 | 17篇 |
1977年 | 25篇 |
1976年 | 25篇 |
1975年 | 30篇 |
1973年 | 20篇 |
1972年 | 21篇 |
排序方式: 共有2788条查询结果,搜索用时 578 毫秒
151.
Cyclophosphamide (CY) in a total dose of 120 mg/kg was given over 2 days on one to three occasions to 12 patients with a variety of nonlymphoid solid tumors. Two of 10 patients with measurable disease had a partial response. One had embryonal rhabdomyosarcoma and the other had ovarian carcinoma. In the 20 treatment courses, the mean leukocyte count was less than 1,000/mm for 7 days. Thrombocytopenia was variable with a mean nadir of 87,000/mm on day 12. There were four instances of local infection, one of bacteremia, and 11 of fever of undetermined origin. Weight gain of 2 or more kg occurred after 12, and EKG changes compatible with cardiotoxicity after six courses of CY. Serial skin testing with recall antigens revealed a frequent transient loss, and in three patients a later overall gain, in responsiveness. All patients were immunized with Vi antigen before CY, and with Vi and sheep red blood cells (SRBC) after CY. Specific immune tolerance to Vi, with a satisfactory response to SRBC, was found in six of 12 patients. Patients' responses to the lymphocytes of 2 ABO compatible normal subjects were measured in mixed lymphocyte culture (MLC) before and after CY. Patients were given 500 ml of whole blood from one of the subjects prior to CY. Following CY, the patients' responses to the blood donors' cells were not significantly lower than their responses to non-donor cells. Thus, tolerance to HL-A antigens was not demonstrable in MLC. Three patients had an increase from subnormal to normal reactivity to non-donor cells in MLC. 相似文献
152.
153.
154.
155.
Juvenile ankylosing spondylitis 总被引:3,自引:0,他引:3
156.
157.
158.
159.
160.
Specialty pharmaceuticals are a unique group of drug agents used to treat complex clinical conditions. Many specialty pharmaceuticals are biological in nature and administered through injection or infusion. Tracking spending on these pharmaceuticals is complex, because these products may be processed as either medical or pharmacy claims. This benchmarking study of ten Blue Cross Blue Shield plans, representing almost eighteen million covered lives, documents large expenditures on select specialty pharmaceutical categories and much variation in spending across plans, age groups, and time. Our results underscore the need for insurers to scrutinize trends in specialty pharmaceutical spending and identify appropriate management strategies. 相似文献